Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.
The Journal of urology · 2022 · 411 citations · John Davis
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021 · 445 citations · Robert Given
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.
The Journal of urology · 2022 · 226 citations · John Davis
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 134 citations · John Davis
Long-Term Outcomes of Recurrent Bulbar Urethral Stricture Treatment With the Optilume Drug-Coated Balloon: Five-Year Results From the ROBUST I Study.
The Journal of urology · 2025 · 36 citations · Ramon Virasoro
Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial.
BJUI compass · 2024 · 52 citations ·
Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
The Journal of urology · 2023 · 45 citations · Gregg Eure
One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume® Drug-Coated Balloon for Anterior Urethral Strictures.
The Journal of urology · 2022 · 77 citations · Melanie Aube-Peterkin, Ramon Virasoro